Polycitra Interactions
There are 253 drugs known to interact with Polycitra (citric acid/potassium citrate/sodium citrate), along with 11 disease interactions. Of the total drug interactions, 104 are major, 99 are moderate, and 50 are minor.
- View all 253 medications that may interact with Polycitra
- View Polycitra disease interactions (11)
Most frequently checked interactions
View interaction reports for Polycitra (citric acid/potassium citrate/sodium citrate) and the medicines listed below.
- acetaminophen
- albuterol
- Allegra-D 12 Hour (fexofenadine / pseudoephedrine)
- bacitracin topical
- baclofen
- calcium carbonate
- Ciprodex (ciprofloxacin / dexamethasone otic)
- clonazepam
- clonidine
- cranberry
- Culturelle Digestive Health (lactobacillus rhamnosus gg)
- Diflucan (fluconazole)
- DuoNeb (albuterol / ipratropium)
- felbamate
- fluticasone nasal
- hydrocortisone topical
- ibuprofen
- Klor-Con (potassium chloride)
- levothyroxine
- MCT (medium chain triglycerides)
- melatonin
- midazolam
- Mylicon (simethicone)
- nitrofurantoin
- norethindrone
- nystatin topical
- Onfi (clobazam)
- Pedialyte (electrolyte replacement solutions)
- polyethylene glycol 3350
- Pulmicort Respules (budesonide)
Polycitra disease interactions
There are 11 disease interactions with Polycitra (citric acid/potassium citrate/sodium citrate) which include:
- sodium/water balance
- inflammatory bowel disease
- intestinal obstruction disorders
- UTI
- dehydration
- familial periodic paralysis
- hyperkalemia
- renal dysfunction
- GI irritation
- acid/base balance
- alkalosis
More about Polycitra (citric acid/potassium citrate/sodium citrate)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.